ACM
BRLI

American Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

American Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-356,120
Closed -$14.7M – 72
2015
Q2 		$14.7M Sell
356,120
-20,740
-6% -$744K 1.4% 27
2015
Q1 		$13.3M Buy
376,860
+8,910
+2% +$301K 1.31% 28
2014
Q4 		$11.8M Buy
367,950
+2,100
+0.6% +$60.7K 1.28% 28
2014
Q3 		$10.3M Buy
365,850
+15,000
+4% +$457K 1.19% 28
2014
Q2 		$10.6M Buy
350,850
+10,000
+3% +$276K 1.19% 28
2014
Q1 		$9.44M Buy
340,850
+15,350
+5% +$402K 1.11% 30
2013
Q4 		$8.31M Buy
325,500
+3,000
+0.9% +$92.5K 1.03% 32
2013
Q3 		$9.64M Hold
322,500
– – 1.29% 27
2013
Q2 		$9.27M Buy
+322,500
New +$8.89M 1.39% 22

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

American Capital Management's BRLI Position: Q3 2015 in Review

American Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 356,120 shares — an estimated $14.7M sold.

American Capital Management first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $14.7M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • American Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • American Capital Management sold 356,120 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $14.7M.
  • American Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • American Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $14.7M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on American Capital Management's 13F filing for Q3 2015, filed 3 Nov 2015.